Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future

Abstract

Hydrogen sulfide (H2S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H2S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H2S modulates various components of metabolic syndrome, including obesity and glucose metabolism. This review will discuss studies exhibiting H2S -derived cardioprotective signaling in heart failure with reduced ejection fraction (HFrEF). We will also discuss the role of H2S in metabolic syndrome and heart failure with preserved ejection fraction (HFpEF).

Keywords

• HFpEF
• HFrEF
• metabolic syndrome
• obesity
• cardiometabolic HFpEF
• hydrogen sulfide therapeutics